BU-NOT-SET

CONTACT US
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Global expansion in the CDMO field
  • Industry trends
Eyes
Insight
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
Insight
  • Industry trends
Post-Brexit medicines - stuck in the UK?
Insight
  • Industry trends
Brexit: What will it mean for the regulation of medicines?
Insight
  • Analytical chemistry
Stability study trends - Outsourcing stability studies
Insight
  • Industry trends
The EMA relocation: Brexit and the UK's pharmaceutical industry
Insight
  • Drug product
Prevention not cure: avoiding a European prescription opioid epidemic
Insight
  • Manufacturing
Six months and counting: industry views
Insight
  • Manufacturing
Six months until DSCSA… industry comments
Insight
  • Manufacturing
Ensuring serialisation success
Insight
  • Manufacturing
Serialisation ready?